A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

Manhattan-based dentist Dr. Sandip Sachar and obesity medicine specialist Dr. Meghan Garcia-Webb discuss the prevalence of ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...

According to the Centers for Disease Control and Prevention, new data reveal that depression is becoming more prevalent in the United States.

I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

Hansal Mehta's weight loss journey using Mounjaro sparked debate in India. AIIMS endocrinologist Dr. Yashdeep Gupta ...

CeCe Olisa is a trailblazing voice in inclusive health and beauty, dedicated to inspiring plus-size and Black women to ...

She had also spent the previous several years struggling to conceive—a common issue for folks with PCOS because of how the ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

Since Ozempic hit the public consciousness as a weight-loss medication, one in eight Americans have tried it (or a version of it) to lose weight.

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...